FDA approves implant to curb drugs craving

US health officials have approved an innovative new option for people struggling with addiction to heroin and painkillers: a slow-release implant that curbs craving and withdrawal symptoms for six months at a time.

The first-of-a-kind device, Probuphine, arrives as communities across the US grapple with a wave of addiction tied to opioids

The implant from Braeburn Pharmaceuticals is essentially a new, long-term